DE1436140U - - Google Patents

Info

Publication number
DE1436140U
DE1436140U DENDAT1436140D DE1436140DU DE1436140U DE 1436140 U DE1436140 U DE 1436140U DE NDAT1436140 D DENDAT1436140 D DE NDAT1436140D DE 1436140D U DE1436140D U DE 1436140DU DE 1436140 U DE1436140 U DE 1436140U
Authority
DE
Germany
Prior art keywords
ird
velrlngdrt
ufdßsum
uchsun
tteprfiche
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1436140D
Other languages
German (de)
English (en)
Publication of DE1436140U publication Critical patent/DE1436140U/de
Active legal-status Critical Current

Links

Landscapes

  • Hybrid Cells (AREA)
  • Primary Cells (AREA)
DENDAT1436140D Active DE1436140U (enExample)

Publications (1)

Publication Number Publication Date
DE1436140U true DE1436140U (enExample)

Family

ID=744865

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1436140D Active DE1436140U (enExample)

Country Status (1)

Country Link
DE (1) DE1436140U (enExample)

Similar Documents

Publication Publication Date Title
AU691504B2 (en) Immunologic enhancement with intermittent interleukin-2 therapy
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Redding et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis
Krown et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study
Yarchoan et al. The National Cancer Institute phase I study of 2′, 3′-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles
DE1436140U (enExample)
US5696079A (en) Immunologic enhancement with intermittent interleukin-2 therapy
Khanlou et al. Co-administration of atazanavir with proton-pump inhibitors and H2 blockers
CN1281623C (zh) 抗病毒活性的人α干扰素衍生物
CN1943564A (zh) 吲达帕胺缓释片及其制备方法
CN1187054C (zh) 含中药环维黄杨星d的渗透泵控释制剂及其制备方法
RU2004129000A (ru) Способ нанесения покрытия
WO2019107986A1 (ko) 피마살탄을 포함하는 약학적 조성물
OHASHI et al. Effects of interferon-α on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells
CN1145592C (zh) 一种硅酸钙绝热制品及其制备方法
DE1409138U (enExample)
Lefkowitz et al. Cocaine inhibits production of murine hepatitis virus by peritoneal macrophages in vitro
Sneller Cytokine therapy of HIV infection
CN1163271C (zh) 一种合成肽流感疫苗的制备方法
Sathish Kumar et al. Chronic mucocutaneous candidiasis in a child
Gigout et al. Consequences of ddI-induced reduction of acute SIVmac251 virus load on cytokine profiles in cynomolgus macaques
CN1502339A (zh) 稀土杂多酸盐（蓝）类抗艾滋病药物及其制备方法
CN1108815C (zh) 复方α干扰素含片及其制备方法
Bettoli et al. Cutaneous cryptococcosis in AIDS: successful treatment with itraconazole: Haut‐Cryptococcose bei AIDS: Erfolgreiche Behandlung mit Itraconazol
CN1166318A (zh) 盐酸万乃洛韦及其药物组合物治疗乙型肝炎的用途